HanchorBio Inc. (TWSE: 7827)
Health Care · Biotechnology · TW
NT$169.00
+1.20% today · +118.1% 1Y
HanchorBio Inc. (TWSE: 7827) operates in the Biotechnology industry within the Health Care sector. The company is valued at $739.81M.
Over the last twelve months the share price has gained 118.1%, trading between 63.70 and 187.00.
Tweenvest scores HanchorBio Inc. across four factors: quality 48/100, value 47/100. Its strongest factor is quality.
7827 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $739.81M
- Revenue (TTM)
- $10.11M
- P/E
- —
- EPS
- -4.46
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$187.00
- 52-week low
- NT$63.70
- Avg volume (3M)
- —
- Shares outstanding
- 139.97M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shenzhen Weiguang Biological Products Co., Ltd.SZSE: 002880 | $758.81M | CN¥22.41 | +0.81% |
| Inventiva S.A.ENXTPA: IVA | $756.65M | €2.86 | -9.06% |
| Gyre Therapeutics, Inc.NasdaqCM: GYRE | $746.48M | $7.04 | -0.98% |
| JS Link, Inc.KOSDAQ: A127120 | $743.20M | ₩28,750.00 | -1.54% |
| Solid Biosciences Inc.NasdaqGS: SLDB | $736.64M | $6.87 | +0.29% |
| 4D Molecular Therapeutics, Inc.NasdaqGS: FDMT | $736.41M | $13.33 | +4.96% |
| Avalo Therapeutics, Inc.NasdaqCM: AVTX | $732.05M | $13.65 | +1.64% |
| Design Therapeutics, Inc.NasdaqGS: DSGN | $729.08M | $11.65 | +1.39% |
Figures last refreshed Oct 11, 2026.